FDA Investigator Yvonne C Wilkes

Yvonne C Wilkes has inspections in 1 countries as of 09 Nov 2023. Yvonne C Wilkes has collaborated with a combinined 3583 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
354
Last Inspection Date:
09 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby Lmozeke Baker, Adam J Taylor, Alexander M Kay, Alexandra B Pitkin, Amalia C Himaya, Amalia Himaya, Amy A Johnson, Amy W Yan Mai, Ana Djurdjevic, Ana S Cabrera, Anderson, Andrew K Haack, PhD, Andy B Lee, Angel K Sandhu, Angelina M Albert, Anita Narula, PhD, Annette Melendez, April P Shaw, Armando Chavez, MS, Arsen Karapetyan, Barbara G Peoples, Barry Cherney, PhD, Beverly A Thomas, Bichsa T Nguyen, Bichsa T Tran, Bo Chi, PhD, Bowman, Brentley S Collins, Brian P Putz, Brien C Fox, Bryce A May, Carla J Lundi, Carol B Czerniak, Caryn M Mcnab, Celeta S Coves, Charles D Boison, Charles L Larson, Cheron M Portee, Christina V Santos, Colleen M Aspinwall, Comyar Shoghi, Courtney N Long, Creighton T Tuzon, Daniel J Lahar, Daniel W Cline, Darla J Christopher, Davinna Ligons, PhD, Davis, Deborah A Greco, Dennis M Farley, Diana L Ayala, Diana M Rand, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Don A Leeseberg, Donna Ltartaglino Besone, Donna Mwilliams Hill, Doretha M Tonkins, Doretha M Wilson, Dyana K Stone, Dylan R Jock, Emily B Camire, Emily S Mcgann, Firasat H Ghori, Frances Namuswe, PhD, Gabriel M Guevarra, Gail L Katz, Garrad R Poole, Gene D Arcy, Gerald T O'connor, Grace P Santos, Haley H Seymour, Haley Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Herminio C Francisco, Hoimay Chan, Hoover, Iris C Macinnes, Jaclyn N Munsch, Jacqueline M Bowling, James R Fleckenstein, Janet Pulver, Jee Chung, PhD, Jeffrey P Raimondi, Jennifer C Adams, Jennifer C Johnson, Jennifer Gogley, Jennifer L Custodio, Jennifer M Foley, Jennifer M Gogley, Jinnie Kokiatkulkij, Jocelyn E Massey, Joel Welch, PhD, John A Iwen, John L Stevens, John R Myung, Joseph C Yen, Julian C Hanson, Jun Park, PhD, Ka L Wong, Karen J Bak, Kathleen B Swat, Kathleen R Jones, PhD, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kenneth S Boehnen, Kim Lthomas Cruse, Kimberly M Lichter, Lakecha N Lewis, Laura E Garcia, Laura Fontan, MS, Lauren E Swantko, Lauren M Lilly, PhD, Laurie A Haxel, Laurissa S Flowers, Laverne Kimble, Lawrence H Howell, LCDR Jennifer H Rhyu, Leeterry Moore, Leonard H Lavi, Linda Thai, Lisa Shin, Lore Fields, Lori J Silverstein, Maida Henesian (NMI), Marcia Britt Williams, Marcus F Yambot, Mary Ewilkerson Brinsko, Mary R Hole, Matthew J Gretkierewicz, Maxyne T Lam, Melissa D Kalik, Michael D Garcia, Michelle A Marsh, Mihaly S Ligmond, Minh D Phan, Mizanne E Lewis, Mohsen Rajabi Abhari, FDA, Mpris Inspector, Naveen B Walker, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nikisha M Bolden, Omotunde O Osunsanmi, Paul M Chefor, Peter Kessler, PhD, Peter S Diak, Raymond W Brullo, Rebecca Rodriguez, Richard J Bashay, Richard L Bartlett, Richard T Riggie, Richmond K Yip, Robert D Tollefsen, Robert Darius, Robert M Tillman, Robert S Sweeton, Roger D Gawne, Roger F Zabinski, Roger J Adams, Ronald L Koller, Ronda Lebland, Sandra Sejdinovic, Sarah Arden, Sarah Forney, Scott K Zika, Scott R Nichols, PhD, Sean P Desbrow, Seyyida Saterfield, Shaquenta Y Perkins, Shelley H Beausoleil, Sherri J Jackson, Sidney B Priesmeyer, Simone E Pitts, Sonia R Peterson, Sonya L Karsik, Stanley Au, Steven E Porter, Jr, Steven Fong, MS, PhD, Taichun Qin, PhD, Tania L Sawyer, Tania Y Hall, Tawny L Colling, Terrance L Thomas, Terri L Dodds, Terri L Jones, Thanh B Tran, Thanh M Andrews, Thao T Kwan, Thao Tran, Thao X Tran, Timothy P Lafave, Tonia L Sawyer, Travis R Hunt, Trushani T Desai, Uttaniti Limchumroon (Tom), Vanessa R Muller, Vashti E Bocker, Vien Q Le, Virgilio F Pacio, CSO, William F Lagud, Jr, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne T Lacour

Yvonne C Wilkes's Documents

Publish Date Document Type Title
May, 2016 EIR Tissue Banks International Inc - EIR, 2016-05-26
January, 2020 FDA 483 California Fertility Centers, A Medical Corporation - Form 483, 2020-01-24
June, 2012 FDA 483 Pacific Coast Tissue Bank - Form 483, 2012-06-19
March, 2022 FDA 483 Incinta Fertility Center, LLC - Form 483, 2022-03-03
June, 2014 EIR Scantibodies Laboratory, Inc. - EIR, 2014-06-16
December, 2016 EIR Access Biologicals LLC - EIR, 2016-12-14
March, 2015 FDA 483 Response Banner Desert Medical Center - Form 483R, 2015-03-08
August, 2021 FDA 483 University Fertility Laboratory, Inc. - Form 483, 2021-08-10
May, 2013 FDA 483 Scantibodies Laboratory, Inc. - Form 483, 2013-05-24
January, 2018 FDA 483 StemGenex Biologic Laboratories, LLC - Form 483, 2018-01-26
June, 2022 FDA 483 American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc. - Form 483, 2022-06-09
March, 2015 EIR Banner Desert Medical Center - EIR, 2015-03-06
October, 2021 FDA 483 Fangyinmeng MD Inc. - Form 483, 2021-10-22
March, 2015 FDA 483 Banner Desert Medical Center - Form 483, 2015-03-06
April, 2006 EIR VA GLA Health Care System (WLA) 113 - EIR, 2006-04-04
February, 2019 FDA 483 University Fertility Laboratory, Inc. - Form 483, 2019-02-04
September, 2008 FDA 483 Hemacare Corp - Form 483, 2008-09-18
November, 2016 EIR Brooks Life Sciences - EIR, 2016-12-06
June, 2014 FDA 483 Scantibodies Laboratory, Inc. - Form 483, 2014-06-16
December, 2010 EIR HemaCare Corp Dba USC Blood Center - University Village - EIR, 2010-12-20
May, 2013 EIR Scantibodies Laboratory, Inc. - EIR, 2013-05-24
March, 2020 FDA 483 Lin Fertility Network, Inc. - Form 483, 2020-03-05
September, 2022 FDA 483 UCI Medical Center C/O Blood Bank - Form 483, 2022-09-29
July, 2022 FDA 483 Akyut Bayrak, MD. A Professional Corporation - Form 483, 2022-07-21
February, 2001 FDA 483 Amgen, Inc - Form 483, 2001-02-23
August, 2016 EIR Scantibodies Biologics Inc - EIR, 2016-08-17
February, 2001 EIR Amgen, Inc - EIR, 2001-02-23
July, 2019 FDA 483 VA Long Beach Healthcare System - Form 483, 2019-07-02

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more